<p>根据最近向证券交易委员会（SEC）提交的文件，弗吉尼亚退休系统（VIRGINIA RETIREMENT SYSTEMS ET Al）在第四季度削减了对 Globus Medical, Inc.（NYSE:GMED - 免费报告）的持股 58.0%。该公司在季度内出售了 17,300 股后，持有 12,510 股该医疗设备公司的股票。截至最近的 SEC 文件，弗吉尼亚退休系统在 Globus Medical 的持股价值为 1,092,000 美元。</p>
<p>其他几家对冲基金和机构投资者也对 GMED 的持股进行了增减。AQR Capital Management LLC 在第一季度将其在 Globus Medical 的持股增加了 45.9%。AQR Capital Management LLC 目前持有 22,510 股该医疗设备公司的股票，价值 1,622,000 美元，此前在该期间内又购买了 7,086 股。Integrated Wealth Concepts LLC 在第一季度将其在 Globus Medical 的持股增加了 33.0%。Integrated Wealth Concepts LLC 目前持有 4,375 股该医疗设备公司的股票，价值 320,000 美元，此前在该期间内又购买了 1,085 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Globus Medical 的持股增加了 38.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 30,649 股该医疗设备公司的股票，价值 2,228,000 美元，此前在该期间内又购买了 8,540 股。Jones Financial Companies Lllp 在第一季度将其在 Globus Medical 的持股增加了 237.3%。Jones Financial Companies Lllp 目前持有 850 股该医疗设备公司的股票，价值 62,000 美元，此前在该期间内又购买了 598 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Globus Medical 的持股增加了 8.8%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前持有 347,527 股该医疗设备公司的股票，价值 25,439,000 美元，此前在该期间内又购买了 28,027 股。当前 95.16% 的股票由机构投资者持有。</p>
<p>获取 <strong>Globus Medical</strong> 的提醒：</p>
<h2>分析师设定新目标价</h2>
<p>几位研究分析师对 GMED 股票发表了看法。Truist Financial 在 2 月 25 日的研究报告中将 Globus Medical 的目标价设定为 115.00 美元。加拿大皇家银行在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 115.00 美元上调至 120.00 美元，并给予该股票 “跑赢大盘” 的评级。富国银行在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 104.00 美元下调至 103.00 美元，并为该公司设定了 “增持” 评级。Needham &amp; Company LLC 在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 114.00 美元上调至 117.00 美元，并给予该公司 “买入” 评级。最后，Zacks Research 在 3 月 3 日的研究报告中将 Globus Medical 的评级从 “持有” 上调至 “强烈买入”。两位分析师给予该股票 “强烈买入” 评级，九位给予 “买入” 评级，五位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 106.36 美元。</p>
<p><strong>阅读我们关于 Globus Medical 的最新股票报告</strong></p>
<h2>Globus Medical 的内部交易</h2>
<p>在相关消息中，执行副总裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。该股票以 94.50 美元的平均价格出售，总价值为 1,890,000.00 美元。该交易已在向证券交易委员会的文件中披露，相关文件可通过此链接获取。当前 18.38% 的股票由公司内部人士持有。</p>
<h2>Globus Medical 股票下跌 0.9%</h2>
<p>GMED 的股票在周五开盘价为 76.52 美元。该公司的市值为 103.9 亿美元，市盈率为 17.79，市盈率/增长比率为 1.58，贝塔值为 1.00。该公司的 50 日移动平均线为 87.78 美元，200 日移动平均线为 87.08 美元。Globus Medical, Inc.的 52 周低点为 51.79 美元，52 周高点为 101.40 美元。</p>
<p>Globus Medical（NYSE:GMED - 获取免费报告）最近在 5 月 7 日发布了季度财报。该医疗设备公司报告每股收益（EPS）为 1.12 美元，超出分析师一致预期的 0.92 美元，超出幅度为 0.20 美元。该公司在季度内的收入为 7.5985 亿美元，而一致预期为 7.4035 亿美元。Globus Medical 的股本回报率为 13.46%，净利润率为 18.92%。Globus Medical 的收入同比增长 27.0%。去年同期，该公司每股收益为 0.68 美元。Globus Medical 已将其 2026 财年的指导目标设定为 4.700-4.800 EPS。整体来看，研究分析师预计 Globus Medical, Inc.在当前财年将发布 4.74 的每股收益。</p>
<h2>Globus Medical 简介</h2>
<p>（免费报告）</p>
<p>Globus Medical, Inc. NYSE: GMED 是一家领先的医疗设备公司，专注于脊柱和骨科应用的肌肉骨骼解决方案。该公司于 2003 年由 David C. Paul 创立，总部位于宾夕法尼亚州 Audubon，开发、制造和销售旨在治疗脊柱疾病和促进骨愈合的植入设备和外科器械。其产品组合包括用于微创和开放手术的解决方案，包括椎间融合设备、椎弓根螺钉系统和用于增强融合效果的生物制剂。</p>
<p>除了其核心脊柱业务外，Globus Medical 还扩展到机器人和导航系统，以支持手术室的精确性和效率。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票比 Globus Medical 更好</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师喜爱的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 带入 PC 硬件</li>
<li>Peloton 股票在乐观的财报后回吐涨幅</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在 Globus Medical 吗？</h2>
<p>在考虑 Globus Medical 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Globus Medical 并不在名单上。</p>
<p>虽然 Globus Medical 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

Globus医疗

<p>维吉尼亚退休系统等在第四季度减少了对 Globus Medical, Inc.（纽约证券交易所代码：GMED）58% 的持股，出售了 17,300 股。该公司目前持有 12,510 股，价值 1,092,000 美元。其他机构投资者也调整了他们的持股，AQR 资本管理公司将其持股增加了 45.9%。分析师为 GMED 设定了价格目标，平均目标为 106.36 美元。该股票开盘价为 76.52 美元，市值为 103.9 亿美元，最近的财报显示同比收入增长 27%</p>

<p>VIRGINIA RETIREMENT SYSTEMS ET Al trimmed its holdings in Globus Medical, Inc. (NYSE:GMED - Free Report) by 58.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,510 shares of the medical device company's stock after selling 17,300 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al's holdings in Globus Medical were worth $1,092,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>根据最近向证券交易委员会（SEC）提交的文件，弗吉尼亚退休系统（VIRGINIA RETIREMENT SYSTEMS ET Al）在第四季度削减了对 Globus Medical, Inc.（NYSE:GMED - 免费报告）的持股 58.0%。该公司在季度内出售了 17,300 股后，持有 12,510 股该医疗设备公司的股票。截至最近的 SEC 文件，弗吉尼亚退休系统在 Globus Medical 的持股价值为 1,092,000 美元。</p>
</div><p>Several other hedge funds and other institutional investors have also added to or reduced their stakes in GMED. AQR Capital Management LLC boosted its stake in Globus Medical by 45.9% in the 1st quarter. AQR Capital Management LLC now owns 22,510 shares of the medical device company's stock worth $1,622,000 after purchasing an additional 7,086 shares during the period. Integrated Wealth Concepts LLC boosted its stake in Globus Medical by 33.0% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,375 shares of the medical device company's stock worth $320,000 after purchasing an additional 1,085 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in Globus Medical by 38.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 30,649 shares of the medical device company's stock worth $2,228,000 after purchasing an additional 8,540 shares during the period. Jones Financial Companies Lllp boosted its stake in Globus Medical by 237.3% in the 1st quarter. Jones Financial Companies Lllp now owns 850 shares of the medical device company's stock worth $62,000 after purchasing an additional 598 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in Globus Medical by 8.8% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 347,527 shares of the medical device company's stock worth $25,439,000 after purchasing an additional 28,027 shares during the period. 95.16% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也对 GMED 的持股进行了增减。AQR Capital Management LLC 在第一季度将其在 Globus Medical 的持股增加了 45.9%。AQR Capital Management LLC 目前持有 22,510 股该医疗设备公司的股票，价值 1,622,000 美元，此前在该期间内又购买了 7,086 股。Integrated Wealth Concepts LLC 在第一季度将其在 Globus Medical 的持股增加了 33.0%。Integrated Wealth Concepts LLC 目前持有 4,375 股该医疗设备公司的股票，价值 320,000 美元，此前在该期间内又购买了 1,085 股。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第一季度将其在 Globus Medical 的持股增加了 38.6%。MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.目前持有 30,649 股该医疗设备公司的股票，价值 2,228,000 美元，此前在该期间内又购买了 8,540 股。Jones Financial Companies Lllp 在第一季度将其在 Globus Medical 的持股增加了 237.3%。Jones Financial Companies Lllp 目前持有 850 股该医疗设备公司的股票，价值 62,000 美元，此前在该期间内又购买了 598 股。最后，UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 在第一季度将其在 Globus Medical 的持股增加了 8.8%。UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC 目前持有 347,527 股该医疗设备公司的股票，价值 25,439,000 美元，此前在该期间内又购买了 28,027 股。当前 95.16% 的股票由机构投资者持有。</p>
</div><p>Get <strong>Globus Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Globus Medical</strong> 的提醒：</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析师设定新目标价</h2>
</div><p>Several research analysts have weighed in on GMED shares. Truist Financial set a $115.00 price target on Globus Medical in a research note on Wednesday, February 25th. Royal Bank Of Canada upped their price target on Globus Medical from $115.00 to $120.00 and gave the stock an &#34;outperform&#34; rating in a research note on Friday, May 8th. Wells Fargo &amp; Company dropped their price target on Globus Medical from $104.00 to $103.00 and set an &#34;overweight&#34; rating for the company in a research note on Friday, May 8th. Needham &amp; Company LLC increased their target price on Globus Medical from $114.00 to $117.00 and gave the company a &#34;buy&#34; rating in a research report on Friday, May 8th. Finally, Zacks Research upgraded Globus Medical from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of &#34;Moderate Buy&#34; and an average price target of $106.36.</p>
<div class="lb-trans"><p>几位研究分析师对 GMED 股票发表了看法。Truist Financial 在 2 月 25 日的研究报告中将 Globus Medical 的目标价设定为 115.00 美元。加拿大皇家银行在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 115.00 美元上调至 120.00 美元，并给予该股票 “跑赢大盘” 的评级。富国银行在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 104.00 美元下调至 103.00 美元，并为该公司设定了 “增持” 评级。Needham &amp; Company LLC 在 5 月 8 日的研究报告中将 Globus Medical 的目标价从 114.00 美元上调至 117.00 美元，并给予该公司 “买入” 评级。最后，Zacks Research 在 3 月 3 日的研究报告中将 Globus Medical 的评级从 “持有” 上调至 “强烈买入”。两位分析师给予该股票 “强烈买入” 评级，九位给予 “买入” 评级，五位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的平均评级为 “适度买入”，平均目标价为 106.36 美元。</p>
</div><p><strong>Read Our Latest Stock Report on Globus Medical</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 Globus Medical 的最新股票报告</strong></p>
</div><h2>Insider Transactions at Globus Medical</h2>
<div class="lb-trans"><h2>Globus Medical 的内部交易</h2>
</div><p>In related news, EVP Kelly Huller sold 20,000 shares of the firm's stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $94.50, for a total value of $1,890,000.00. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. 18.38% of the stock is currently owned by corporate insiders.</p>
<div class="lb-trans"><p>在相关消息中，执行副总裁 Kelly Huller 在 2 月 25 日的交易中出售了 20,000 股公司的股票。该股票以 94.50 美元的平均价格出售，总价值为 1,890,000.00 美元。该交易已在向证券交易委员会的文件中披露，相关文件可通过此链接获取。当前 18.38% 的股票由公司内部人士持有。</p>
</div><h2>Globus Medical Stock Down 0.9%</h2>
<div class="lb-trans"><h2>Globus Medical 股票下跌 0.9%</h2>
</div><p>Shares of GMED opened at $76.52 on Friday. The company has a market cap of $10.39 billion, a PE ratio of 17.79, a P/E/G ratio of 1.58 and a beta of 1.00. The business has a fifty day moving average of $87.78 and a 200 day moving average of $87.08. Globus Medical, Inc. has a 52-week low of $51.79 and a 52-week high of $101.40.</p>
<div class="lb-trans"><p>GMED 的股票在周五开盘价为 76.52 美元。该公司的市值为 103.9 亿美元，市盈率为 17.79，市盈率/增长比率为 1.58，贝塔值为 1.00。该公司的 50 日移动平均线为 87.78 美元，200 日移动平均线为 87.08 美元。Globus Medical, Inc.的 52 周低点为 51.79 美元，52 周高点为 101.40 美元。</p>
</div><p>Globus Medical (NYSE:GMED - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The medical device company reported $1.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.92 by $0.20. The company had revenue of $759.85 million during the quarter, compared to the consensus estimate of $740.35 million. Globus Medical had a return on equity of 13.46% and a net margin of 18.92%.Globus Medical's revenue was up 27.0% on a year-over-year basis. During the same period last year, the company earned $0.68 earnings per share. Globus Medical has set its FY 2026 guidance at 4.700-4.800 EPS. As a group, research analysts anticipate that Globus Medical, Inc. will post 4.74 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Globus Medical（NYSE:GMED - 获取免费报告）最近在 5 月 7 日发布了季度财报。该医疗设备公司报告每股收益（EPS）为 1.12 美元，超出分析师一致预期的 0.92 美元，超出幅度为 0.20 美元。该公司在季度内的收入为 7.5985 亿美元，而一致预期为 7.4035 亿美元。Globus Medical 的股本回报率为 13.46%，净利润率为 18.92%。Globus Medical 的收入同比增长 27.0%。去年同期，该公司每股收益为 0.68 美元。Globus Medical 已将其 2026 财年的指导目标设定为 4.700-4.800 EPS。整体来看，研究分析师预计 Globus Medical, Inc.在当前财年将发布 4.74 的每股收益。</p>
</div><h2>Globus Medical Profile</h2>
<div class="lb-trans"><h2>Globus Medical 简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Globus Medical, Inc NYSE: GMED is a leading medical device company specializing in musculoskeletal solutions for spine and orthopaedic applications. Founded in 2003 by David C. Paul and headquartered in Audubon, Pennsylvania, the company develops, manufactures and markets implantable devices and surgical instruments designed to treat spinal disorders and promote bone healing. Its product portfolio encompasses solutions for minimally invasive and open surgical procedures, including interbody fusion devices, pedicle screw systems, and biologics used to enhance fusion outcomes.</p>
<div class="lb-trans"><p>Globus Medical, Inc. NYSE: GMED 是一家领先的医疗设备公司，专注于脊柱和骨科应用的肌肉骨骼解决方案。该公司于 2003 年由 David C. Paul 创立，总部位于宾夕法尼亚州 Audubon，开发、制造和销售旨在治疗脊柱疾病和促进骨愈合的植入设备和外科器械。其产品组合包括用于微创和开放手术的解决方案，包括椎间融合设备、椎弓根螺钉系统和用于增强融合效果的生物制剂。</p>
</div><p>In addition to its core spine business, Globus Medical has expanded into robotics and navigation systems to support precision and efficiency in the operating room.</p>
<div class="lb-trans"><p>除了其核心脊柱业务外，Globus Medical 还扩展到机器人和导航系统，以支持手术室的精确性和效率。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than Globus Medical</li>
<li>3 Stocks to Own If Gas Prices Keep Rising</li>
<li>3 Crucial Aerospace Component Makers That Analysts Love</li>
<li>Alphabet's Googlebook Brings Gemini AI to PC Hardware</li>
<li>Peloton Stock Gives Back Gains After Upbeat Earnings Report</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 Globus Medical 更好</li>
<li>如果油价持续上涨，值得拥有的三只股票</li>
<li>分析师喜爱的三家关键航空航天组件制造商</li>
<li>Alphabet 的 Googlebook 将 Gemini AI 带入 PC 硬件</li>
<li>Peloton 股票在乐观的财报后回吐涨幅</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=GMED"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Globus Medical 吗？</h2>
</div><p>Before you consider Globus Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Globus Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只股票，顶级分析师正在悄悄地向客户推荐在更广泛的市场注意到之前购买……而 Globus Medical 并不在名单上。</p>
</div><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Globus Medical 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

VIRGINIA RETIREMENT SYSTEMS ET Al Sells 17,300 Shares of Globus Medical, Inc. $GMED

Market Beat

Truist Financial

加拿大皇家银行

富国银行

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

弗吉尼亚退休系统等机构出售了 17,300 股 Globus 医疗公司的股票，代码为$GMED